Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Prevalencia y factores de riesgo para discapacidades de grado 2 entre los niños y adolescentes recién diagnosticados de lepra: un análisis basado en las historias clínicas de la India

Upputuri B, Vulchi N, Singh R, et al. Revista de leprología. 2022; 93 (1) : 79-88.
Publication

Prevalence and risk factors for grade 2 disability among newly diagnosed leprosy in children and adolescents: a record-based analysis from India

Upputuri B, Vulchi N, Singh R, et al. Lepra. Leprosy Review. 2022; 93 (1) : 79-88.
Download PDF
Publication

Perfil epidemiológico dos casos de hanseniase em menores de 15 anos no estado de Pernambuco, Brasil

Lima Filho CAD, Silva MVBD, Bernardino Cavalcanti de Albuquerque ADO, et al. RECIMA21 - Revista Cientifica Multidisciplinar. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 2022; 3 (5) : e351423.
Download PDF
Publication

Dapsone induced hemolysis in a patient with Hansen's disease and G6PD deficiency: A preventable peril.

Ghorui A, Patra P. Clinical case reports. 2022; 10 (4) : e05700.
Download PDF
Publication

Spatial distribution pattern of new leprosy cases under 15 years of age and their contacts in Sobral, Ceará, Brazil

Linhares MSC, Kerr LRFS, Kendall C, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2022; 27 (4) : 1641-1652.
Download PDF
Publication

Incapacidades físicas da hanseníase em menores de 15 anos no estado do Tocantins, Brasil, 2001 a 2020

Carvalho RA, Alencar JLG, Souza SMD, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (5) : e18311527995.
Download PDF
Publication

Comportamento epidemiológico da hanseníase em vários países da América Latina, 2011-2020.

Cáceres-Durán M. Revista panamericana de salud publica = Pan American journal of public health. 2022;
Download PDF
Publication

Pediatric leprosy: no child's play.

Mehta H, Narang T, Dogra S, et al. International journal of dermatology. 2022;
Publication

Deep Vein Thrombosis in Lepromatous Leprosy: A Case Report of Secondary Pediatric Antiphospholipid Syndrome.

Jones D, CA J, Joshi A, et al. Cureus. 2022; 14 (1) : e21361.
Download PDF
Publication

Clinical and epidemiological trends in childhood leprosy: A 20-year retrospective analysis from a tertiary care hospital in Jammu, North India.

Sakral A, Dogra N, Dogra D, et al. Indian journal of dermatology, venereology and leprology. 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 12
  • Next page ››
Subscribe to Children

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD